Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System | MicrobiomeTrials← Back to trialsNCT03331380
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2018-01-05Est. Completion: 2028-05-31
Enrollment target: 2,950 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029
Heterozygous Familial Hypercholesterolemia (HeFH)
A phase 1/2, two-part trial consisting of an open label dose-escalation part and a randomized, double blind, placebo-con…
Charlestown, AustraliaEst. completion Jun 2029
Coronary Artery Disease
The goal of this study is to compare the 10-year clinical outcomes of an initial strategy of percutaneous coronary inter…
Pune, IndiaCompleted Aug 24, 2026